Table (IMAGE)

European Society for Medical Oncology

Table

Caption

Immunotherapy improves survival in some patients with metastatic triple negative breast cancer, according to late-breaking results from the IMpassion130 trial reported at the ESMO 2018 Congress in Munich.

Credit

© European Society for Medical Oncology

Usage Restrictions

To be used with the appropriate caption or credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.